cached image

Brian T. Terpstra, Ph.D.

Neurology University of Cincinnati, Cincinnati, OH 
Parkinson's disease
"Brian Terpstra"
Cross-listing: Neurotree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Paumier KL, Sortwell CE, Madhavan L, et al. (2015) Tricyclic antidepressant treatment evokes regional changes in neurotrophic factors over time within the intact and degenerating nigrostriatal system. Experimental Neurology. 266: 11-21
Paumier KL, Sortwell CE, Madhavan L, et al. (2015) Chronic amitriptyline treatment attenuates nigrostriatal degeneration and significantly alters trophic support in a rat model of parkinsonism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 874-83
Gombash SE, Lipton JW, Collier TJ, et al. (2012) Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 544-54
Thompson VB, Koprich JB, Chen EY, et al. (2012) Prenatal exposure to MDMA alters noradrenergic neurodevelopment in the rat. Neurotoxicology and Teratology. 34: 206-13
Kordower JH, Dodiya HB, Kordower AM, et al. (2011) Transfer of host-derived α synuclein to grafted dopaminergic neurons in rat. Neurobiology of Disease. 43: 552-7
Spieles-Engemann AL, Behbehani MM, Collier TJ, et al. (2010) Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss. Neurobiology of Disease. 39: 105-15
Lipton JW, Tolod EG, Thompson VB, et al. (2008) 3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture. Neuropharmacology. 55: 851-9
Terpstra BT, Collier TJ, Marchionini DM, et al. (2007) Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons. Journal of Neuroscience Methods. 166: 13-9
Kordower JH, Kanaan NM, Chu Y, et al. (2006) Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys. Annals of Neurology. 60: 264-8
Terpstra B, Collier T, Kanaan N, et al. (2006) Re-evaluation of systemic proteasome inhibition as an animal model for Parkinson's disease Experimental Neurology. 198: 590-591
See more...